Inactive Instrument
CannPal Animal Therapeutics Limited Stock
Stocks
CP1
AU000000CP17
Biotechnology & Medical Research
| 1 day | +6.25% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2016-06-02 | |
Baden Bowen
DFI | Director of Finance/CFO | - | 2016-09-30 |
Rayson Tan
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoff Starr
CHM | Chairman | - | 2017-07-06 |
Robert Clifford
BRD | Director/Board Member | - | 2016-07-31 |
| Director/Board Member | - | 2016-06-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.25% | +13.33% | - | - | 12.26M | |
| +1.03% | +2.30% | +55.91% | +114.22% | 56.42B | |
| +2.72% | +3.26% | +46.05% | +44.91% | 44.54B | |
| +1.12% | +2.79% | -15.04% | -21.68% | 22.9B | |
| +1.17% | +3.85% | -0.89% | +403.86% | 21.21B | |
| +3.81% | -5.07% | +11.00% | -30.62% | 16.4B | |
| +0.15% | +2.24% | +9.32% | -39.30% | 15.4B | |
| -0.69% | +0.82% | +27.75% | +176.72% | 13.35B | |
| +5.27% | +5.54% | +19.65% | - | 12.36B | |
| +1.61% | +1.28% | +95.75% | +205.26% | 11.15B | |
| Average | +2.24% | +2.09% | +27.72% | +106.67% | 23.75B | |
| Weighted average by Cap. | +1.72% | +2.37% | +32.04% | +99.60% |
Employees
-
